Patient Partner Involvement in Research

Throughout the website, we use the Patient-Centered Outcomes Research Institute (PCORI)’s definition of patient partners, which includes patients (those with lived experience), family members, caregivers, and the organizations that are representative of the population of interest in a particular study.

Our ambition: The importance and merits of patient involvement in research are commonly acknowledged. When patients are involved, everyone benefits, because it ensures clinical and medical research work is performed more effectively and advances the delivery of what patients really need. This can only be achieved based on the collaborative identification and understanding of patients’ unmet needs. Receiving patient input throughout the design, implementation, and evaluation of clinical trials helps improve the discovery, development, and evaluation of new treatments. The process of creating these recommendations has been published at the in the journal, Research Involvement and Engagement.

Our guidance to the application requirements are divided in:

Step 1: Pre-application grant

These small grants are to close the funding gap for patient experts to provide input to the development of a grant application/protocol. We are aiming at supporting patient organizations during this early phase with a budget. The budget should be planned to cover travel costs to preparatory meetings and the work time invested by staff or patient experts.. For more information, please refer to the pre-application grant guidelines.

Step 2: Choice of model of Patient Involvement in research projects

Applicants will be asked to provide a detailed explanation justifying the patient role selected for the project. Please refer to our description of patient roles in our funding guidelines.

Step 3: Patient involvement planning checklist

This checklist contains some important Patient Engagement points to be considered in the application phase, during the implementation of the project, and beyond. For more information, please refer to our funding guidelines.

Step 4: Completing the Patient Involvement Plan template

The plan should describe Patient Involvement processes during both the generation of the project application and the implementation of your project. It describes engagement, provides a clear description of the expected outputs and how patient input will be processed and incorporated. Please download the plan template here.

Step 5: Review of applications by patient partners

Beside the Patient Involvement Plan, a set of questions will be asked to give the patient partners reviewing each application a clearer picture of what patient needs are being addressed and how. Please download the questions here and carefully address them in your application.

Webinar series​

Partnering with Patients to Improve Clinical Trials

We invite you to watch our webinar series, developed in partnership with the LUNGevity Foundation, to explore the vital role that people with cancer can play in developing clinical trials. Through engaging panelist presentations and discussions, these webinars highlight flagship collaborations from both the patient partner’s and the researcher’s perspectives.
 

In the first episode of our series, we highlight a collaboration between a patient partner and a clinician aimed at developing patient-centric endpoints for a geriatric prostate cancer clinical trial.

The second episode of our webinar series demonstrates how researchers and patient partners can co-design clinical trials that truly resonate with patients and address their most pressing concerns. Based on insights from the lung cancer community.

The third episode of our webinar series illustrates the transformative impact of patient partner involvement in the research process. By examining the POSITIVE study, a breast cancer-focused clinical trial, we explore real-world examples of successful patient partner-researcher collaborations.

Patient Involvement Materials

RTFCCR funding guidelines

DIA considerations guide to implementing patient-centric initiatives in health care product development

Recommendations on patient involvement for funding institutions

Recommendations on patient involvement for applicants of collaborative research grants

Recommendation for patient organizations and patient advocates on their involvement in collaborative research projects

Empfehlungen Patientenorganisationen und Patientenvertreter zur Beteiligung an kollaborativen Forschungsprojekten

Adopting recommendations for implementing patient involvement in cancer research a funder’s approach

The Rising Tide Foundation and Patvocates have jointly developed guidance documents to support public and private health research funding institutions, research teams, and patient organizations with recommendations on organizational models, potential patient community contributions, checklists, and templates that support patient involvement in the generation of calls for proposals, the preparation and review of grant applications, and the implementation of research projects.

These recommendations are based on patient engagement models and methodologies established by leading collaborative initiatives, such as EUPATI, PFMD, PARADIGM and INVOLVE; interviews of patient engagement experts in patient organizations, funding institutions, regulatory authorities and academic institutions in the USA and Europe; as well as practical experience of patient advocates in the Patvocates team.

Funding Opportunities

Open Call

We accept letter of intent (LOIs) all year round and do not have specific deadlines. Once you have submitted your LOI, you will receive further information regarding timing and next steps.

Pre-application Grants

Pre-application grants provide gap funding to support patient experts’ helping to develop grant applications/ protocols.

Focus Areas

Science of Early Detection and Intervention

Advancing Cancer Research in Underserved Areas

Scroll to Top

Identifying Clinically Relevant Endpoints People Actually Care About​

The first webinar features our grantee Dr. Shabbir Alibhai, professor of Medicine at the Princess Margaret Cancer Centre and University of Toronto; Janet Freeman-Daily, co-founder and president of the ROS1ders; and Winston Klaas, past chairman and associate director of Prostate Cancer Support Toronto. It is hosted by Dr. Upal Basu Roy, LUNGevity’s executive director of Research. You can watch the entire conversation or use the timestamps below to find specific topics of interest.  

Panelist Introductions: 0:00 – 3:59  

  • Dr. Shabbir Alibhai, professor of Medicine at the Princess Margaret Cancer Centre and University of Toronto;   
  • Janet Freeman-Daily, co-founder and president of the ROS1ders;   
  • Winston Klaas, past chairman and associate director of Prostate Cancer Support Toronto.   

Researcher Insights: 4:00 – 19:50  
Dr. Alibhai speaks about how his team has conducted three studies that involved patients in clinical trial design. He shares his experiences and learnings from working closely with patients to understand their perspectives.  

Patient Insights: 19:43 – 31:30  
Winston Klaas talks about being a patient and being part of the clinical trial design process. He shares his tips and key considerations for how researchers can engage with patients successfully.   

Discussion: 31:30 – 55:49  
In a discussion led by Janet Freeman-Daily, the panelists unearth important details about effective collaboration. Their conversation highlights key skills for researchers and for patients to use when successfully collaborating on research studies. 

Developing Clinical Trials that Account for the Realities of Patient Life

In this second video, LUNGevity again partnered with Rising Tide for Clinical Cancer Research to show how researchers and patient advocates can be empowered with tools to create clinical trials that resonate with patients and address the key issues they care about.

Introductions: 0:00 – 3:22
Meet moderator Karolina Werynska, PhD, scientific program manager for Rising Tide Foundation for Clinical Cancer Research, as she introduces the panelists.

  • Janet Freeman-Daily, patient research advocate and co-founder of ROS1ders
  • Ross Camidge, MD, PhD, professor of medicine-medical oncology at the University of Colorado

Laying the Groundwork for Patient Involvement: 3:22 – 14:29
Panelists explain what interventional clinical trials are—studies of the safety and effectiveness of a treatment—and how patients can get involved in providing guidance and feedback. The panelists also offer examples of why the patient perspective is so important.

Helping Researchers Find Patient Partners: 14:30 – 23:48
In an open discussion, panelists offer suggestions for how researchers can find patients interested in getting involved in research. They provide real-world examples of researchers who have adjusted their clinical trial protocols based on patient feedback. In addition, they offer a deeper understanding of how much patient input is realistically possible to incorporate in clinical trial design.

Addressing FAQs for Researchers 23:49 – 31:15
Panelists discuss the timeline and planning needed to optimally involve patients in clinical trial design. They underscore the need for more patients to get involved in developing clinical trials and offer an example of a great community-wide effort in lung cancer to engage patients.

Wrap-up Discussion and Key Takeaways 31:16 – 41:10
Here the panelists discuss the importance of using patient-centric endpoints in clinical trials. They also offer resources for researchers and patients interested in learning more about collaborating on clinical trial design.

Designing clinical trials: Learnings from breast cancer research

In the final video in our three-part series, LUNGevity and Rising Tide for Clinical Cancer Research partnered again to illustrate the power of having patients contribute to the research process. We use a real-world example to learn about patient-researcher collaborations through the POSITIVE study, a breast cancer-focused clinical trial.

Introductions: 0:00 – 1:54
Meet moderator Alexandre Costa Alencar, MD, head of cancer research programs at Rising Tide Foundation for Clinical Cancer Research, as he establishes the goals of this webinar series and introduces the panelists.

  • Teresa Ferriero, PhD, patient partner of the POSITIVE study
  • Olivia Pagani, MD, scientific chair of the POSITIVE study
  • Monica Ruggeri, operational lead of the POSITIVE study

Explaining the POSITIVE study: 2:10 – 5:59
Learn more about the POSITIVE study, an international clinical trial of 500 patients, to understand its important goals. 

How the Collaboration Began: 6:00 – 10:52
The panelists emphasize the importance of the POSITIVE study and discuss how initial patient survey data allowed the researchers to begin the study design process with patients’ needs in mind.

Examples of Empowering Patients: 10:53 – 25:17
Here the panelists discuss the roles of patient involvement in many aspects of the POSITIVE clinical trial—including participation in the steering committee, fundraising events, and dissemination of study results. 

Effective Involvement of Patients: 25:18 – 50:25
Researchers share their key considerations when choosing patients to collaborate with. They also note that it’s time-consuming to identify the right patients and build these relationships—but the investment is worth the impact. Don’t miss this frank discussion as the panelists explain their expectations from the collaboration process, such as including financial compensation and emotional fulfillment.

Wrap-up Discussion and Key Takeaways: 50:26 – 59:10
Panelists discuss the biggest learnings and challenges from collaborating on the POSITIVE study and offer final tips for successful patient-researcher partnerships.